WEKO3
アイテム
{"_buckets": {"deposit": "5ab91cd7-a2f9-496b-a5df-a87418c82472"}, "_deposit": {"created_by": 19, "id": "509", "owners": [19], "pid": {"revision_id": 0, "type": "depid", "value": "509"}, "status": "published"}, "_oai": {"id": "oai:ompu.repo.nii.ac.jp:00000509", "sets": ["105"]}, "author_link": ["1613"], "control_number": "509", "item_10006_alternative_title_1": {"attribute_name": "その他(別言語等)のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "(前立腺がんにおいて、RB1欠失はRNASEH2B欠失によるPARP阻害剤感受性を無効化する)"}]}, "item_10006_date_granted_11": {"attribute_name": "学位授与年月日", "attribute_value_mlt": [{"subitem_dategranted": "2023-03-01"}]}, "item_10006_degree_grantor_9": {"attribute_name": "学位授与機関", "attribute_value_mlt": [{"subitem_degreegrantor": [{"subitem_degreegrantor_name": "大阪医科薬科大学"}], "subitem_degreegrantor_identifier": [{"subitem_degreegrantor_identifier_name": "34401", "subitem_degreegrantor_identifier_scheme": "kakenhi"}]}]}, "item_10006_degree_name_8": {"attribute_name": "学位名", "attribute_value_mlt": [{"subitem_degreename": "博士(医学)"}]}, "item_10006_description_10": {"attribute_name": "学位授与年度", "attribute_value_mlt": [{"subitem_description": "2022", "subitem_description_type": "Other"}]}, "item_10006_dissertation_number_12": {"attribute_name": "学位授与番号", "attribute_value_mlt": [{"subitem_dissertationnumber": "乙博医第18号"}]}, "item_10006_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.57371/0000000509", "subitem_identifier_reg_type": "JaLC"}]}, "item_10006_link_22": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_link_url": "https://www.science.org/doi/10.1126/sciadv.abl9794"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorAffiliations": [{"affiliationNames": [{"affiliationNameLang": "ja"}]}], "creatorNames": [{"creatorName": "辻野, 拓也", "creatorNameLang": "ja"}, {"creatorName": "ツジノ, タクヤ", "creatorNameLang": "ja-Kana"}], "nameIdentifiers": [{"nameIdentifier": "1613", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2023-04-14"}], "displaytype": "simple", "download_preview_message": "", "file_order": 0, "filename": "2022-os-018_主論文(辻野拓也).pdf", "filesize": [{"value": "29.8 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 29800000.0, "url": {"label": "主論文", "url": "https://ompu.repo.nii.ac.jp/record/509/files/2022-os-018_主論文(辻野拓也).pdf"}, "version_id": "27486b6f-baa1-426e-a1e7-77fe3b2e713c"}, {"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2023-04-14"}], "displaytype": "simple", "download_preview_message": "", "file_order": 1, "filename": "2022-os-018_論文内容要旨/論文審査結果要旨(辻野拓也).pdf", "filesize": [{"value": "332.7 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 332700.0, "url": {"label": "論文内容要旨/論文審査結果要旨", "url": "https://ompu.repo.nii.ac.jp/record/509/files/2022-os-018_論文内容要旨/論文審査結果要旨(辻野拓也).pdf"}, "version_id": "20ea8a64-4d45-409e-b442-42454115f1b5"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "thesis", "resourceuri": "http://purl.org/coar/resource_type/c_46ec"}]}, "item_title": "RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer", "subitem_title_language": "en"}]}, "item_type_id": "10006", "owner": "19", "path": ["105"], "permalink_uri": "https://doi.org/10.57371/0000000509", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2023-04-14"}, "publish_date": "2023-04-14", "publish_status": "0", "recid": "509", "relation": {}, "relation_version_is_last": true, "title": ["RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer"], "weko_shared_id": -1}
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
https://doi.org/10.57371/0000000509
https://doi.org/10.57371/0000000509b2be67e5-b7c6-4fc2-b248-a5f0d25b15e2
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
||
![]() |
Item type | 学位論文 / Thesis or Dissertation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2023-04-14 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_46ec | |||||
資源タイプ | thesis | |||||
ID登録 | ||||||
ID登録 | 10.57371/0000000509 | |||||
ID登録タイプ | JaLC | |||||
その他(別言語等)のタイトル | ||||||
その他のタイトル | (前立腺がんにおいて、RB1欠失はRNASEH2B欠失によるPARP阻害剤感受性を無効化する) | |||||
著者 |
辻野, 拓也
× 辻野, 拓也 |
|||||
DOI | ||||||
https://www.science.org/doi/10.1126/sciadv.abl9794 | ||||||
学位名 | ||||||
学位名 | 博士(医学) | |||||
学位授与機関 | ||||||
学位授与機関識別子Scheme | kakenhi | |||||
学位授与機関識別子 | 34401 | |||||
学位授与機関名 | 大阪医科薬科大学 | |||||
学位授与年度 | ||||||
内容記述タイプ | Other | |||||
内容記述 | 2022 | |||||
学位授与年月日 | ||||||
学位授与年月日 | 2023-03-01 | |||||
学位授与番号 | ||||||
学位授与番号 | 乙博医第18号 |